BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36614118)

  • 21. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
    Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
    Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
    Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
    Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
    Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
    Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
    Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis.
    Zhou F; Dong H; Liu Y; Yan L; Sun C; Hao P; Liu Y; Zhai J; Liu Y
    Brain Res Bull; 2018 Jun; 140():281-290. PubMed ID: 29807145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis.
    Palomo V; Tosat-Bitrian C; Nozal V; Nagaraj S; Martin-Requero A; Martinez A
    ACS Chem Neurosci; 2019 Mar; 10(3):1183-1196. PubMed ID: 30785719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-amyloid triggers ALS-associated TDP-43 pathology in AD models.
    Herman AM; Khandelwal PJ; Stanczyk BB; Rebeck GW; Moussa CE
    Brain Res; 2011 Apr; 1386():191-9. PubMed ID: 21376022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAR DNA-binding protein 43 oligomers in physiology and pathology.
    Lye YS; Chen YR
    IUBMB Life; 2022 Aug; 74(8):794-811. PubMed ID: 35229461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmuscle myosin IIB regulates Parkin-mediated mitophagy associated with amyotrophic lateral sclerosis-linked TDP-43.
    Jun MH; Jang JW; Jeon P; Lee SK; Lee SH; Choi HE; Lee YK; Choi H; Park SW; Kim J; Jang DJ; Lee JA
    Cell Death Dis; 2020 Nov; 11(11):952. PubMed ID: 33154354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.